Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Felix

Showing results (131-140 of 147) with videos related to

Pageof 15
Sort By:
Genome Biology|June 25, 2014
SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpointsJulia Vogt, Kathrin Bengesser, Kathleen B M Claes, et al.
International Journal of Molecular Sciences|May 24, 2020
C-Fiber Loss as a Possible Cause of Neuropathic Pain in SchwannomatosisSaid C Farschtschi, Tina Mainka, Markus Glatzel, et al.
Human Mutation|November 3, 2011
Characterization of the nonallelic homologous recombination hotspot PRS3 associated with type-3 NF1 deletionsAntje M Zickler, Stephanie Hampp, Ludwine Messiaen, et al.
Nucleic Acids Research|November 9, 2018
Human Disease Ontology 2018 update: classification, content and workflow expansionLynn M Schriml, Elvira Mitraka, James Munro, et al.
Nature Neuroscience|March 5, 2013
Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathyAlexander Schulz, Stephan L Baader, Michiko Niwa-Kawakita, et al.
Neuro-Oncology|March 3, 2023
Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entitiesCatena Kresbach, Matthias Dottermusch, Alicia Eckhardt, et al.
Journal of Neuro-Oncology|October 7, 2020
Response to trametinib treatment in progressive pediatric low-grade glioma patientsFlorian Selt, Cornelis M van Tilburg, Brigitte Bison, et al.
The Journal of Clinical Investigation|February 5, 2020
Targetable ERBB2 mutations identified in neurofibroma/schwannoma hybrid nerve sheath tumorsMichael W Ronellenfitsch, Patrick N Harter, Martina Kirchner, et al.
Journal of Medical Genetics|December 12, 2018
Breast cancer risk in neurofibromatosis type 1 is a function of the type of <i>NF1</i> gene mutation: a new genotype-phenotype correlationIan M Frayling, Victor-Felix Mautner, Rick van Minkelen, et al.
American Journal of Medical Genetics. Part A|December 6, 2011
Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2Jaishri O Blakeley, D Gareth Evans, John Adler, et al.
Pageof 15

Showing results (131-140 of 147) with videos related to

Sort By:
Pageof 15
Genome Biology|June 25, 2014
SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpointsJulia Vogt, Kathrin Bengesser, Kathleen B M Claes, et al.
International Journal of Molecular Sciences|May 24, 2020
C-Fiber Loss as a Possible Cause of Neuropathic Pain in SchwannomatosisSaid C Farschtschi, Tina Mainka, Markus Glatzel, et al.
Human Mutation|November 3, 2011
Characterization of the nonallelic homologous recombination hotspot PRS3 associated with type-3 NF1 deletionsAntje M Zickler, Stephanie Hampp, Ludwine Messiaen, et al.
Nucleic Acids Research|November 9, 2018
Human Disease Ontology 2018 update: classification, content and workflow expansionLynn M Schriml, Elvira Mitraka, James Munro, et al.
Nature Neuroscience|March 5, 2013
Merlin isoform 2 in neurofibromatosis type 2-associated polyneuropathyAlexander Schulz, Stephan L Baader, Michiko Niwa-Kawakita, et al.
Neuro-Oncology|March 3, 2023
Atypical neurofibromas reveal distinct epigenetic features with proximity to benign peripheral nerve sheath tumor entitiesCatena Kresbach, Matthias Dottermusch, Alicia Eckhardt, et al.
Journal of Neuro-Oncology|October 7, 2020
Response to trametinib treatment in progressive pediatric low-grade glioma patientsFlorian Selt, Cornelis M van Tilburg, Brigitte Bison, et al.
The Journal of Clinical Investigation|February 5, 2020
Targetable ERBB2 mutations identified in neurofibroma/schwannoma hybrid nerve sheath tumorsMichael W Ronellenfitsch, Patrick N Harter, Martina Kirchner, et al.
Journal of Medical Genetics|December 12, 2018
Breast cancer risk in neurofibromatosis type 1 is a function of the type of <i>NF1</i> gene mutation: a new genotype-phenotype correlationIan M Frayling, Victor-Felix Mautner, Rick van Minkelen, et al.
American Journal of Medical Genetics. Part A|December 6, 2011
Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2Jaishri O Blakeley, D Gareth Evans, John Adler, et al.
Pageof 15